Tenecteplase Acetate for Injection

What is Tenecteplase Acetate for Injection?
Tenecteplase Acetate for Injection is a third-generation thrombolytic agent produced by recombinant DNA technology. It is a modified form of human tissue plasminogen activator (t-PA). Tenecteplase is specifically engineered to have a longer half-life and greater binding affinity for fibrin than its predecessors, allowing for a single-bolus administration. This makes it an essential "clot-buster" in emergency cardiac care where speed is critical to saving heart muscle.
Uses of Tenecteplase Acetate for Injection
Acute Myocardial Infarction (AMI): Reduction of mortality associated with ST-elevation myocardial infarction (STEMI).
Clot Dissolution: Rapidly dissolves occlusive blood clots in the coronary arteries.
Restoration of Blood Flow: Re-establishes perfusion to ischemic heart tissue to prevent permanent damage.
Emergency Pre-hospital Care: Due to its bolus administration, it is often used by paramedics in the field to initiate treatment early.
Acute Ischemic Stroke: Occasionally used off-label in specialized neuro-critical care (under strict clinical protocols).
How Does Tenecteplase Acetate for Injection Work?
Tenecteplase is a fibrin-specific plasminogen activator. It binds to the fibrin component of a thrombus (blood clot) and selectively converts the clot-bound plasminogen into plasmin. Plasmin then digests the fibrin matrix, causing the clot to dissolve. Because it is highly fibrin-specific, it produces less systemic breakdown of circulating fibrinogen compared to older thrombolytics, reducing the risk of widespread bleeding.
FAQs on Tenecteplase Acetate for Injection
1. What is the main advantage of Tenecteplase over Alteplase? The primary advantage is the ease of administration. While Alteplase requires an initial bolus followed by a 90-minute infusion, Tenecteplase is given as a single intravenous bolus over 5–10 seconds. This allows for much faster treatment, which is crucial in the "Golden Hour" of a heart attack.
2. How is the dosage for Tenecteplase determined? The dosage is weight-based. It is carefully calculated according to the patient's body weight to optimize the balance between effective clot dissolution and the risk of bleeding. Pre-filled syringes often come with clear markings to assist in accurate weight-based dosing.
3. What are the contraindications for this medication? As a potent "clot-buster," it cannot be used in patients with a high risk of hemorrhage. This includes individuals with a history of recent hemorrhagic stroke, active internal bleeding, major surgery within the last two months, or severe uncontrolled hypertension.
Therapeutic Category
Cardiovascular (Thrombolytic Agent)
Looking for a reliable Tenecteplase Acetate for Injection manufacturer? Contact Farbe Firma Pvt. Ltd. for dossier support, registration assistance, and export supplies. We provide high-quality, life-saving cardiovascular injectables manufactured in our state-of-the-art sterile facility.